Free Trial

Carmell (CTCXW) Competitors

$0.08 +0.03 (+66.67%)
(As of 12/17/2024 ET)

CTCXW vs. ATNFW, SXTPW, DRTSW, WENAW, APLMW, BCTXW, CDIOW, CELUW, CEROW, and CINGW

Should you be buying Carmell stock or one of its competitors? The main competitors of Carmell include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Anew Medical (WENAW), Apollomics (APLMW), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Celularity (CELUW), CERo Therapeutics (CEROW), and Cingulate (CINGW). These companies are all part of the "biotechnology" industry.

Carmell vs.

Carmell (NASDAQ:CTCXW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, community ranking, media sentiment, earnings, dividends, valuation, institutional ownership, profitability and risk.

Company Net Margins Return on Equity Return on Assets
CarmellN/A N/A N/A
180 Life Sciences N/A N/A N/A

Carmell and 180 Life Sciences both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
CarmellN/AN/A
180 Life SciencesN/AN/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Carmell$32.84KN/AN/AN/AN/A
180 Life SciencesN/AN/AN/AN/AN/A

In the previous week, Carmell's average media sentiment score of 1.87 equaled 180 Life Sciences'average media sentiment score.

Company Overall Sentiment
Carmell Very Positive
180 Life Sciences Very Positive

Summary

Carmell beats 180 Life Sciences on 1 of the 1 factors compared between the two stocks.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CTCXW vs. The Competition

MetricCarmellBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$203.49M$5.14B$9.31B
Dividend YieldN/A3.54%4.81%4.06%
P/E RatioN/A317.19135.1917.53
Price / SalesN/A15,985.321,224.59140.21
Price / CashN/A11.7840.6537.95
Price / BookN/A7.284.884.92
Net IncomeN/A-$18.42M$118.97M$225.78M
7 Day PerformanceN/A187.68%15.53%-1.58%
1 Month PerformanceN/A134.37%15.54%6.67%
1 Year PerformanceN/A113.38%34.63%22.48%

Carmell Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CTCXW
Carmell
N/A$0.08
+66.7%
N/AN/A$0.00$32,839.000.009Gap Up
High Trading Volume
ATNFW
180 Life Sciences
N/A$0.01
flat
N/A+41.0%$0.00N/A0.007Positive News
Gap Down
SXTPW
60 Degrees Pharmaceuticals
N/A$0.02
-51.0%
N/AN/A$0.00$502,409.000.002Gap Up
High Trading Volume
DRTSW
Alpha Tau Medical
N/A$0.20
-20.4%
N/A+4.1%$0.00N/A0.0080News Coverage
Gap Up
WENAW
Anew Medical
N/A$0.04
-0.3%
N/AN/A$0.00N/A0.00N/AGap Down
APLMW
Apollomics
N/A$0.01
flat
N/A-72.3%$0.00N/A0.0059
BCTXW
BriaCell Therapeutics
N/A$0.35
-14.8%
N/A-80.9%$0.00N/A0.008
CDIOW
Cardio Diagnostics
N/A$0.12
+9.5%
N/A-48.0%$0.00$35,688.000.007Gap Down
High Trading Volume
CELUW
Celularity
N/A$0.02
flat
N/A+196.3%$0.00$48.20M0.00220Gap Up
High Trading Volume
CEROW
CERo Therapeutics
N/A$0.02
flat
N/AN/A$0.00N/A0.008
CINGW
Cingulate
N/A$0.04
flat
N/A+56.0%$0.00N/A0.0013

Related Companies and Tools


This page (NASDAQ:CTCXW) was last updated on 12/18/2024 by MarketBeat.com Staff
From Our Partners